Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Chinese Journal of Nervous and Mental Diseases ; (12): 454-459, 2016.
Article in Chinese | WPRIM | ID: wpr-503446

ABSTRACT

Objective To explore the relationship between G-protein β3 subunit (GNB3) gene C825T polymor?phism and the weight gain of schizophrenics treated with olanzapine. Methods Ninety schizophrenics of first time hospi?talization were collected and treated with olanzapine for 12 weeks. The changes of body weight and body mass index (BMI) were detected before and after 12-week olanzapine treatment. The GNB3 gene C825T polymorphism in patients was determined by polymerase chain reaction (PCR) and DNA sequencing technique. The correlation of GNB3 gene C825T polymorphism and change of clinical parameters was analyzed. Results Body weight and BMI in patients were all increased significantly after treatment (all P<0.01). Weight gain rate (WGR) and increase of BMI in the TT genotype group were higher than those in the CC genotype group (all P<0.01). WGR and increase of BMI in the T-allele carrier (TT and CT genotypes) were higher than those in the T-allele non-carrier (CC genotype) (all P<0.01). There was signifi?cant difference in distribution of genotypes between WGR ≥7% group (CC 15.69%, CT 54.90%, TT 29.41%) and WGR <7% group (CC 38.46%, CT 43.59%, TT 17.95%) (P<0.05). The frequency of T-allele in the WGR≥7% group (63.33%) was higher than that in the WGR<7%group (39.74%) (P<0.05). Multi-variable linear regression indicated that TT genotype (contrasted with CC genotype) was an influential factor for change of body weight after treatment with olan?zapine (β=1.83, standardized β=0.29, P<0.01). Conclusions The GNB3 gene C825T polymorphism is associated with olanzapine-induced weight gain.

2.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 1076-1077, 2016.
Article in Chinese | WPRIM | ID: wpr-491182

ABSTRACT

Objective To investigate the clinical features and treatment of mycoplasma pneumonia in children,to facilitate clinical diagnosis and improve treatment.Methods A retrospective study was performed,and the data of 48 treated cases of mycoplasma pneumonia were analyzed.Results There were 32 males and 16 females, with male to female ratio of 2:1.Less than 1 year age reported 7 cases,accounted for 14%;1 -3 years,19 cases, accounted for 40%;>3-7 years 18 cases,accounted for 38%;and>7 to 10 years,4 cases,accounted for 8%.The youngest patient was 2 months and 10 days old,while the maximum age of patient reported was 9 years.Conclusion Highest prevalence of mycoplasma pneumonia was in 1 to 7 years age group children.Clinical manifestations were fever,cough and wheezing.Use of azithromycin,erythromycin or combination therapy all achieved good outcome.

3.
Acta Laboratorium Animalis Scientia Sinica ; (6): 158-163, 2016.
Article in Chinese | WPRIM | ID: wpr-486219

ABSTRACT

Objective The purpose of this study was to establish and evaluate a mouse model of sepsis for studying the mechanism of sepsis and development of anti-inflammatory drugs.Methods The sepsis in mice was induced by cecal ligation and puncture ( CLP) .The survival rates, microbial load, liver and kidney damages, cytokines and pathological changes were detected to evaluate the mouse models.Results The death of mice was closely related with the ligated sites. The mice with 50%cecal ligation displayed about 40% of 12-day survival rate, however, all the mice with 75% cecum ligation died within 4 days (P<0.01).Compared with the sham surgery group, the mice with 50% cecal ligation had a high microbial load in the blood and abdominal cavity.Leukopenia was also emerged (P<0.001).CLP mice demonstra-ted elevated levels of serum ALT, AST and BUN (P<0.01).The levels of IL1α, IL6, IL10, MIP1α, MIP1β, and TNFαwere increased a lot.The liver and lung showed obvious pathological injury at 48 h post CLP.Conclusions The established mouse model of CLP shows typical characteristics of sepsis and is an ideal tool for further study of anti-inflam-matory drugs.

SELECTION OF CITATIONS
SEARCH DETAIL